Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 11, 2025 • 3:00 AM ET

Date/Time Source News Release
05/13/2025 04:05 PM EDT Business Wire Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results
05/01/2025 07:00 AM EDT Business Wire Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics
04/25/2025 01:00 PM EDT Business Wire Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
03/31/2025 04:39 PM EDT Business Wire Repare Therapeutics Announces Leadership Transitions
03/07/2025 04:05 PM EST Business Wire Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/03/2025 07:05 AM EST Business Wire Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results
01/09/2025 04:05 PM EST Business Wire Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions
12/12/2024 04:20 PM EST Business Wire Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial
12/10/2024 04:05 PM EST Business Wire Repare Therapeutics to Host Webcast to Report Data from the Lunresertib and Camonsertib Combination Phase 1 MYTHIC Clinical Trial
11/12/2024 07:05 AM EST Business Wire Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib
Page
  • 1
  • 2

Additional News

As of June 11, 2025 • 3:00 AM ET

Date/Time Source News Release
05/13/2025 05:20 PM EDT SeekingAlpha Repare Therapeutics GAAP EPS of -$0.71
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:31 AM EDT US Earnings Reports Expected earnings - Repare Therapeutics Inc.
05/12/2025 09:15 AM EDT Zacks CervoMed Inc. (CRVO) Reports Q1 Loss, Tops Revenue Estimates
05/06/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 6th, 2025
05/06/2025 05:31 AM EDT US Earnings Reports Expected earnings - Repare Therapeutics Inc.
03/31/2025 04:37 PM EDT SeekingAlpha Repare Therapeutics appoints CFO as new CEO
03/11/2025 12:00 PM EDT Zacks What Makes Repare Therapeutics (RPTX) a New Buy Stock
03/03/2025 07:38 AM EST SeekingAlpha Repare Therapeutics GAAP EPS of -$0.67 beats by $0.10
02/26/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Wednesday, February 26th, 2025
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.